Kamyar Kalantar-Zadeh was born on October 1963 and is a US American physician doing research in nephrology, kidney dialysis, nutrition, and epidemiology.
12 Facts About Kamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh is best known as a specialist in kidney disease nutrition and chronic kidney disease and for his hypothesis about the longevity of individuals with chronic disease states, known as reverse epidemiology including obesity paradox.
Kamyar Kalantar-Zadeh is the brother of Kourosh Kalantar-zadeh, who is an Australian scientist involved in research in the fields of materials sciences, nanotechnology, and transducers.
Kamyar Kalantar-Zadeh is a practicing triple board certified physician specialist in internal medicine, pediatrics, and nephrology.
Kamyar Kalantar-Zadeh completed his residency at the State University of New York and his nephrology fellowship at the University of California, San Francisco.
Kamyar Kalantar-Zadeh serves as a part-time staff physician at Tibor-Rubin VA Medical center in Long Beach, California, under the Veterans Health Administration.
Kamyar Kalantar-Zadeh has remained a professor of epidemiology at Fielding UCLA School of Public Health.
Kamyar Kalantar-Zadeh is the past president of the International Society of Renal Nutrition and Metabolism and the past chair of the international steering committee of the World Kidney Day, and current president of the National Forum of the ESRD Networks, the coalition of the 18 congressionally mandated End Stage Renal Disease Program network organizations since 1978.
Kamyar Kalantar-Zadeh first proposed reverse epidemiology in articles in the journal Kidney International in 2003 and in the Journal of the American College of Cardiology in 2004.
Kamyar Kalantar-Zadeh has contributed extensively to the fields of dialysis and kidney disease nutrition including an invited review paper in the New England Journal of Medicine in 2017 on nutritional management of chronic kidney disease, in that he recommends low protein diet for conservative management of chronic kidney disease to delay dialysis initiation but high protein diet for dialysis patients without residual kidney function.
Kamyar Kalantar-Zadeh has published extensively on chronic kidney disease and end-stage renal disease including kidney dialysis with focus on incremental transition to dialysis therapy with initially less frequent hemodialysis treatment.
Kamyar Kalantar-Zadeh has first-authored three review and perspective articles in the New England Journal of Medicine including a 2013 case records paper on metabolic acidosis due to metformin toxicity, a 2017 renal nutrition review paper.